2013
DOI: 10.1371/journal.pone.0056228
|View full text |Cite
|
Sign up to set email alerts
|

canEvolve: A Web Portal for Integrative Oncogenomics

Abstract: Background & ObjectiveGenome-wide profiles of tumors obtained using functional genomics platforms are being deposited to the public repositories at an astronomical scale, as a result of focused efforts by individual laboratories and large projects such as the Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium. Consequently, there is an urgent need for reliable tools that integrate and interpret these data in light of current knowledge and disseminate results to biomedical researchers in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
24
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 39 publications
(24 citation statements)
references
References 51 publications
0
24
0
Order By: Relevance
“…XBP1-CTL (n D 3) induced CD107a degranulation and IFNg production in response to each heteroclitic XBP1 peptide. These functional immune responses were higher than those against K562-A*0201 cells alone or the cells presenting irrelevant IMP [58][59][60][61][62][63][64][65][66] peptide. Importantly, XBP1-CTL recognized and responded to both native and heteroclictic XBP1 unspliced and native XBP1 spliced peptides as seen by comparable levels of CD107a degranulation (6-8%; Fig.…”
Section: Resultsmentioning
confidence: 77%
See 3 more Smart Citations
“…XBP1-CTL (n D 3) induced CD107a degranulation and IFNg production in response to each heteroclitic XBP1 peptide. These functional immune responses were higher than those against K562-A*0201 cells alone or the cells presenting irrelevant IMP [58][59][60][61][62][63][64][65][66] peptide. Importantly, XBP1-CTL recognized and responded to both native and heteroclictic XBP1 unspliced and native XBP1 spliced peptides as seen by comparable levels of CD107a degranulation (6-8%; Fig.…”
Section: Resultsmentioning
confidence: 77%
“…HLA-A2-specific native XBP1 [184][185][186][187][188][189][190][191][192] (NISPWILAV), native XBP1 SP 367-375 (ELFPQLISV), heteroclitic XBP1 [184][185][186][187][188][189][190][191][192] (YISPWILAV), heteroclitic XBP1 SP 367-375 (YLFPQ-LISV), and influenza virus matrix protein [58][59][60][61][62][63][64][65][66] (IMP [58][59][60][61][62][63][64][65][66] : GILGFVFTL) peptides were synthesized by standard fmoc (9-fluorenylmethyl-oxycarbonyl) chemistry, purified to > 95% using reverse-phase chromatography, and validated by mass-spectrometry for molecular weight (Biosynthesis). Lyophilized peptides were dissolved in DMSO (Sigma), diluted in AIM-V medium (Gibco-Life Technologies), and stored at ¡140 C.…”
Section: Synthetic Peptidesmentioning
confidence: 99%
See 2 more Smart Citations
“…However, tools for analyzing epigenomic and transcriptomic level information are very limited. Currently, a small number of web-based tools (such as cBio [11,12], Wanderer [13], canEvolve [14] Web-TCGA [15] and TCGA compass [16] are available to access TCGA data for further analysis. However, these tools have several limitations with regard to flexible and systematic analysis of epigenomic data.…”
Section: For Reprint Orders Please Contact: Reprints@futuremedicinecommentioning
confidence: 99%